In the context of an HIV‐1 infection, we hypothesized that co‐infections with additional pathogens could worsen the clinical prognosis, masking the potential beneficial effects of Siglec‐1 truncation in HIV‐1 mono‐infected individuals. Here, SIGLEC1 is linked to coinfection.